Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Urology
Volume 2013 (2013), Article ID 915874, 4 pages
http://dx.doi.org/10.1155/2013/915874
Case Report

Long-Term Survival of a Patient with Invasive Signet-Ring Cell Carcinoma of the Urinary Bladder Managed by Combined S-1 and Cisplatin Adjuvant Chemotherapy

Department of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya 467-8601, Japan

Received 25 March 2013; Accepted 13 April 2013

Academic Editors: A. Greenstein, S. K. Hong, A. Marte, and J. Park

Copyright © 2013 Takashi Hamakawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Grignon, J. Y. Ro, A. G. Ayala, and D. E. Johnson, “Primary signet-ring cell carcinoma of the urinary bladder,” The American Journal of Clinical Pathology, vol. 95, no. 1, pp. 13–20, 1991. View at Google Scholar · View at Scopus
  2. G. Jakse, H. M. Schneider, and G. H. Jacobi, “Urachal signet-ring cell carcinoma, a rare variant of vesical adenocarcinoma: incidence and pathological criteria,” Journal of Urology, vol. 120, no. 6, pp. 764–766, 1978. View at Google Scholar · View at Scopus
  3. I. Romics, E. Székely, and A. Szendroi, “Signet-ring cell carcinoma arising from the urinary bladder,” The Canadian Journal of Urology, vol. 15, no. 5, pp. 4266–4268, 2008. View at Google Scholar · View at Scopus
  4. S. Akamatsu, A. Takahashi, M. Ito, and K. Ogura, “Primary signet-ring cell carcinoma of the urinary bladder,” Urology, vol. 75, no. 3, pp. 615–618, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Fiter, F. Gimeno, L. Martin, and L. Gomez Tejeda, “Signet-ring cell adenocarcinoma of bladder,” Urology, vol. 41, no. 1, pp. 30–33, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Naeim, R. M. Schlezinger, and L. M. de la Maza, “Primary signet ring cell carcinoma of the bladder: report of a case and review of the literature,” Journal of Urology, vol. 108, no. 2, pp. 274–276, 1972. View at Google Scholar · View at Scopus
  7. M. L. Blute, D. E. Engen, W. D. Travis, L. K. Kvols, and G. R. Prout, “Primary signet ring cell adenocarcinoma of the bladder,” Journal of Urology, vol. 141, no. 1, pp. 17–21, 1989. View at Google Scholar · View at Scopus
  8. K. Tsumatani, K. Arai, K. Kurooka et al., “Primary signet-ring cell carcinoma of the urinary bladder: report of a case,” Hinyokika Kiyo, vol. 34, no. 8, pp. 1449–1454, 1988. View at Google Scholar
  9. H. Amemiya, A. Iwasaki, R. Hata et al., “Primary signet-ring cell carcinoma of the urinary bladder: a case report,” Nishinihon Journal of Urology, vol. 52, no. 5, pp. 636–638, 1990. View at Google Scholar
  10. Y. Tsukumo and A. Sakamoto, “Signet ring cell carcinoma of the urinary bladder detected by urine cytology: a case report,” Japanese Journal of Diagnostic Pathology, vol. 22, no. 1, pp. 54–57, 2005. View at Google Scholar
  11. Y. Nanpo, K. Ito, and M. Kitagawa, “Primary signet-ring cell carcinoma of the urinary bladder with elevated serum carcinoembryonic antigen and carbohydrate antigen 19-9: a case report,” Japanese Journal of Urological Surgery, vol. 18, no. 4, pp. 357–361, 2005. View at Google Scholar
  12. M. Fujita, T. Otoshi, K. Kobayashi et al., “Primary signet-ring cell carcinoma of the urinary bladder: a case report,” Hinyokika Kiyo, vol. 55, no. 9, pp. 579–582, 2009. View at Google Scholar
  13. E. V. Braun, M. Ali, A. O. Fayemi, and E. Beaugard, “Primary signet-ring cell carcinoma of the urinary bladder: review of the literature and report of a case,” Cancer, vol. 47, no. 6, pp. 1430–1435, 1981. View at Google Scholar · View at Scopus
  14. S. A. Bernstein, V. E. Reuter, P. R. Carroll, and W. F. Whitmore, “Primary signet-ring cell carcinoma of urinary bladder,” Urology, vol. 31, no. 5, pp. 432–436, 1988. View at Google Scholar · View at Scopus
  15. B. E. Harris, R. Song, S. J. Soong, and R. B. Diasio, “Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion,” Cancer Research, vol. 50, no. 1, pp. 197–201, 1990. View at Google Scholar · View at Scopus
  16. T. Shirasaka, Y. Shimamato, H. Ohshimo et al., “Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators,” Anti-Cancer Drugs, vol. 7, no. 5, pp. 548–557, 1996. View at Google Scholar · View at Scopus
  17. T. Shirasaka, Y. Shimamoto, and M. Fukushima, “Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats,” Cancer Research, vol. 53, no. 17, pp. 4004–4009, 1993. View at Google Scholar · View at Scopus
  18. K. Sugimachi, Y. Maehara, N. Horikoshi et al., “An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers,” Oncology, vol. 57, no. 3, pp. 202–210, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Sakuramoto, M. Sasako, T. Yamaguchi et al., “Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine,” The New England Journal of Medicine, vol. 357, no. 18, pp. 1810–1820, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Koizumi, H. Narahara, T. Hara et al., “S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial,” The Lancet Oncology, vol. 9, no. 3, pp. 215–221, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Kojima, Y. Yamada, H. Kamisawa, S. Sasaki, Y. Hayashi, and K. Kohri, “Complete response of a recurrent advanced urachal carcinoma treated by S-1/cisplatin combination chemotherapy,” International Journal of Urology, vol. 13, no. 8, pp. 1123–1125, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Shirasaka, Y. Shimamoto, H. Ohshimo, H. Saito, and M. Fukushima, “Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo,” Cancer Chemotherapy and Pharmacology, vol. 32, no. 3, pp. 167–172, 1993. View at Google Scholar · View at Scopus